AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
CONSTRUCTION OF RECOMBINANT ADENOVIRUS ENCODING MOUSE INTERLEUKIN-18 WITH INTERLEUKIN-1 RECEPTOR ANTAGONIST SIGNAL SEQUENCE
Authors: HE L ZHANG WP YUAN ZL CAO XT
Citation: L. He et al., CONSTRUCTION OF RECOMBINANT ADENOVIRUS ENCODING MOUSE INTERLEUKIN-18 WITH INTERLEUKIN-1 RECEPTOR ANTAGONIST SIGNAL SEQUENCE, European cytokine network, 9(3), 1998, pp. 208-208
AUGMENTATION OF HEMATOPOIESIS BY FIBROBLAST-MEDIATED INTERLEUKIN-6 GENE-THERAPY IN MICE WITH CHEMOTHERAPY
Authors: CAO XT CAI R JU DW TAO Q YU YZ WANG JL
Citation: Xt. Cao et al., AUGMENTATION OF HEMATOPOIESIS BY FIBROBLAST-MEDIATED INTERLEUKIN-6 GENE-THERAPY IN MICE WITH CHEMOTHERAPY, Journal of interferon & cytokine research, 18(4), 1998, pp. 227-233
B-CELLS INHIBIT INDUCTION OF T-CELL-DEPENDENT TUMOR-IMMUNITY
Authors: QIN ZH RICHTER G SCHULER T IBE S CAO XT BLANKENSTEIN T
Citation: Zh. Qin et al., B-CELLS INHIBIT INDUCTION OF T-CELL-DEPENDENT TUMOR-IMMUNITY, Nature medicine, 4(5), 1998, pp. 627-630
EFFECTS OF FIBROBLAST-MEDIATED INTERLEUKIN-3 AND INTERLEUKIN-6 GENE-THERAPY ON HEMATOPOIESIS IN MICE TREATED WITH 5-FLUOROURACIL
Authors: CAO XT JU DW CAI R TAO Q YU YZ WANG JL
Citation: Xt. Cao et al., EFFECTS OF FIBROBLAST-MEDIATED INTERLEUKIN-3 AND INTERLEUKIN-6 GENE-THERAPY ON HEMATOPOIESIS IN MICE TREATED WITH 5-FLUOROURACIL, Journal of molecular medicine, 76(11), 1998, pp. 782-789
T-CELL TOLERIZATION OR ACTIVATION-INDUCED BY MHC I-RESTRICTED TUMOR-ANTIGEN PEPTIDES PRESENTED IN DIFFERENT WAYS
Authors: ZHU XJ ZHANG MH CAO XT
Citation: Xj. Zhu et al., T-CELL TOLERIZATION OR ACTIVATION-INDUCED BY MHC I-RESTRICTED TUMOR-ANTIGEN PEPTIDES PRESENTED IN DIFFERENT WAYS, Journal of leukocyte biology, 1998, pp. 24-24
CHEMOATTRACTIVE EFFECT ON THE EFFECTOR-CELLS OF THE SUPERNATANTS FROMMELANOMA-CELLS TRANSFECTED WITH THE INTERLEUKIN-2 (IL-2), IL-4 OR IL-6 GENE
Authors: CAO XT CHEN GY HE L ZHANG WP YU YZ YE TX
Citation: Xt. Cao et al., CHEMOATTRACTIVE EFFECT ON THE EFFECTOR-CELLS OF THE SUPERNATANTS FROMMELANOMA-CELLS TRANSFECTED WITH THE INTERLEUKIN-2 (IL-2), IL-4 OR IL-6 GENE, Journal of cancer research and clinical oncology, 124(2), 1998, pp. 88-92
ACCELERATED RECOVERY OF IRRADIATION-INDUCED BONE-MARROW DEPRESSION BYFIBROBLAST-MEDIATED INTERLEUKIN-6 GENE-THERAPY IN COMBINATION WITH BONE-MARROW TRANSPLANTATION IN MICE
Authors: CAO XT CAI R JU DW TAO Q YU YZ WANG JL
Citation: Xt. Cao et al., ACCELERATED RECOVERY OF IRRADIATION-INDUCED BONE-MARROW DEPRESSION BYFIBROBLAST-MEDIATED INTERLEUKIN-6 GENE-THERAPY IN COMBINATION WITH BONE-MARROW TRANSPLANTATION IN MICE, Transplantation, 65(3), 1998, pp. 325-331
ESCULENTOSIDE-A INHIBITS TUMOR-NECROSIS-FACTOR, INTERLEUKIN-1, AND INTERLEUKIN-6 PRODUCTION INDUCED BY LIPOPOLYSACCHARIDE IN MICE
Authors: JU DW ZHENG QY CAO XT FANG J WANG HB
Citation: Dw. Ju et al., ESCULENTOSIDE-A INHIBITS TUMOR-NECROSIS-FACTOR, INTERLEUKIN-1, AND INTERLEUKIN-6 PRODUCTION INDUCED BY LIPOPOLYSACCHARIDE IN MICE, Pharmacology, 56(4), 1998, pp. 187-195
LYMPHOTACTIN GENE-MODIFIED BONE-MARROW DENDRITIC CELLS ACT AS MORE POTENT ADJUVANTS FOR PEPTIDE DELIVERY TO INDUCE SPECIFIC ANTITUMOR IMMUNITY
Authors: CAO XT ZHANG WP HE L XIE ZF MA SH TAO Q YU YZ HAMADA H WANG JL
Citation: Xt. Cao et al., LYMPHOTACTIN GENE-MODIFIED BONE-MARROW DENDRITIC CELLS ACT AS MORE POTENT ADJUVANTS FOR PEPTIDE DELIVERY TO INDUCE SPECIFIC ANTITUMOR IMMUNITY, The Journal of immunology (1950), 161(11), 1998, pp. 6238-6244
ELICITING T-CELL IMMUNITY AGAINST POORLY IMMUNOGENIC TUMORS BY IMMUNIZATION WITH DENDRITIC CELL-TUMOR FUSION VACCINES
Authors: WANG JL SAFFOLD S CAO XT KRAUSS J CHEN W
Citation: Jl. Wang et al., ELICITING T-CELL IMMUNITY AGAINST POORLY IMMUNOGENIC TUMORS BY IMMUNIZATION WITH DENDRITIC CELL-TUMOR FUSION VACCINES, The Journal of immunology (1950), 161(10), 1998, pp. 5516-5524
IN-VIVO GENE-THERAPY OF MURINE MELANOMA MEDIATED BY RECOMBINANT VACCINIA VIRUS ENCODING HUMAN IL-2 GENE
Authors: WAN T CAO XT JU DW ACES B
Citation: T. Wan et al., IN-VIVO GENE-THERAPY OF MURINE MELANOMA MEDIATED BY RECOMBINANT VACCINIA VIRUS ENCODING HUMAN IL-2 GENE, International journal of oncology, 10(4), 1997, pp. 703-708
ENHANCED ANTITUMOR EFFECTS OF TUMOR ANTIGEN-PULSED DENDRITIC CELLS BYTHEIR TRANSFECTION WITH GM-CSF GENE
Authors: CAO XT ZHANG WP MA SH ZHANG MH WANG JL YE TX
Citation: Xt. Cao et al., ENHANCED ANTITUMOR EFFECTS OF TUMOR ANTIGEN-PULSED DENDRITIC CELLS BYTHEIR TRANSFECTION WITH GM-CSF GENE, SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 40(5), 1997, pp. 539-545
IN-VIVO DISTRIBUTION AND GENE-EXPRESSION OF GENETICALLY-MODIFIED HEPATOCYTES AFTER INTRASPLENIC TRANSPLANTATION
Authors: ZHANG WP CAO XT HUANG X WANG JL TAO Q YE TX
Citation: Wp. Zhang et al., IN-VIVO DISTRIBUTION AND GENE-EXPRESSION OF GENETICALLY-MODIFIED HEPATOCYTES AFTER INTRASPLENIC TRANSPLANTATION, SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 40(5), 1997, pp. 554-560
IL-3 GENE-MODIFIED BONE-MARROW STROMAL CELLS ACCELERATE HEMATOPOIESISRECOVERY OF TUMOR-BEARING MICE AFTER HIGH-DOSE CHEMOTHERAPY
Authors: ZHANG MH YU YZ CAO XT
Citation: Mh. Zhang et al., IL-3 GENE-MODIFIED BONE-MARROW STROMAL CELLS ACCELERATE HEMATOPOIESISRECOVERY OF TUMOR-BEARING MICE AFTER HIGH-DOSE CHEMOTHERAPY, Cancer gene therapy, 4(6), 1997, pp. 88-88
IMMUNOLOGICAL CHARACTERISTICS OF IL-2 GENE-MODIFIED, IFN-GAMMA INDUCED HUMAN PRIMARY SKIN FIBROBLAST CELLS
Authors: WAN T TAN Q CAO XT
Citation: T. Wan et al., IMMUNOLOGICAL CHARACTERISTICS OF IL-2 GENE-MODIFIED, IFN-GAMMA INDUCED HUMAN PRIMARY SKIN FIBROBLAST CELLS, Cancer gene therapy, 4(6), 1997, pp. 153-153
IMMUNOLOGICAL CHARACTERISTICS OF THE LEUKEMIA-CELLS TRANSFECTED WITH ONCOSTATIN-M GENE BY RECOMBINANT ADENOVIRUS
Authors: WANG QX HAMADA H CAO XT
Citation: Qx. Wang et al., IMMUNOLOGICAL CHARACTERISTICS OF THE LEUKEMIA-CELLS TRANSFECTED WITH ONCOSTATIN-M GENE BY RECOMBINANT ADENOVIRUS, Cancer gene therapy, 4(6), 1997, pp. 154-154
LOCAL CYTOKINE PRODUCTION MAY PARTICIPATE IN THE ANTITUMOR RESPONSE INDUCED BY COMBINED THERAPY OF CD SUICID GENE AND GM-CSF SCF GENE-TRANSFER/
Authors: CAO XT HUANG X ZHANG WP JU DW ZHAO ZL YU YZ
Citation: Xt. Cao et al., LOCAL CYTOKINE PRODUCTION MAY PARTICIPATE IN THE ANTITUMOR RESPONSE INDUCED BY COMBINED THERAPY OF CD SUICID GENE AND GM-CSF SCF GENE-TRANSFER/, Cancer gene therapy, 4(6), 1997, pp. 155-155
LYMPHOTACTIN GENE-MODIFIED BONE-MARROW DENDRITIC CELLS ACT AS MORE POTENT ADJUVANT FOR PEPTIDE DELIVERY TO INDUCE ANTITUMOR IMMUNITY
Authors: CAO XT ZHANG WP HE L YUAN ZL XIE ZF MA SH HAMADA H WANG JL
Citation: Xt. Cao et al., LYMPHOTACTIN GENE-MODIFIED BONE-MARROW DENDRITIC CELLS ACT AS MORE POTENT ADJUVANT FOR PEPTIDE DELIVERY TO INDUCE ANTITUMOR IMMUNITY, Cancer gene therapy, 4(6), 1997, pp. 156-156
THE ENHANCEMENT OR SUPPRESSION OF ANTITUMOR IMMUNE-RESPONSE BY GM-CSFIL-4 GENE-MODIFIED TUMOR VACCINE WHEN IMMUNIZED THROUGH DIFFERENT PATHWAYS/
Authors: ZHU XJ YU YZ ZHAO Y TAO Q JU DW ZHANG WP CAO XT
Citation: Xj. Zhu et al., THE ENHANCEMENT OR SUPPRESSION OF ANTITUMOR IMMUNE-RESPONSE BY GM-CSFIL-4 GENE-MODIFIED TUMOR VACCINE WHEN IMMUNIZED THROUGH DIFFERENT PATHWAYS/, Cancer gene therapy, 4(6), 1997, pp. 157-157
THERAPEUTIC EFFECT OF INTRATUMORAL INJECTION OF ADENOVIRUS CARRYING INTERLEUKIN-18 GENE
Authors: HE L ZHANG WP CAO XT
Citation: L. He et al., THERAPEUTIC EFFECT OF INTRATUMORAL INJECTION OF ADENOVIRUS CARRYING INTERLEUKIN-18 GENE, Cancer gene therapy, 4(6), 1997, pp. 158-158
DENDRITIC CELLS PLAY IMPORTANT ROLES IN THE ANTITUMOR EFFECTS OF ADENOVIRUS-MEDIATED GM-CSF GENE AND CYTOSINE DEAMINASE GENE-TRANSFER FOLLOWED BY 5-FLUOROCYTOSINE TREATMENT IN TUMOR-BEARING MICE
Authors: JU DW WANG BM CAO XT
Citation: Dw. Ju et al., DENDRITIC CELLS PLAY IMPORTANT ROLES IN THE ANTITUMOR EFFECTS OF ADENOVIRUS-MEDIATED GM-CSF GENE AND CYTOSINE DEAMINASE GENE-TRANSFER FOLLOWED BY 5-FLUOROCYTOSINE TREATMENT IN TUMOR-BEARING MICE, Cancer gene therapy, 4(5), 1997, pp. 308-308
THE REDUCED TUMORIGENICITY AND INCREASED IMMUNOGENICITY OF INTERLEUKIN-18 GENE-TRANSFECTED TUMOR-CELLS
Authors: HE L ZHANG WP CHEN GY ZHOU H MA SH HAMADA H CAO XT
Citation: L. He et al., THE REDUCED TUMORIGENICITY AND INCREASED IMMUNOGENICITY OF INTERLEUKIN-18 GENE-TRANSFECTED TUMOR-CELLS, Cancer gene therapy, 4(5), 1997, pp. 320-320
THE ANTITUMOR CAPACITY OF THE ANTIBODY FROM THE MICE INDUCED BY IL-4 GENE-MODIFIED TUMOR VACCINE
Authors: YU YZ LEI H CAO XT
Citation: Yz. Yu et al., THE ANTITUMOR CAPACITY OF THE ANTIBODY FROM THE MICE INDUCED BY IL-4 GENE-MODIFIED TUMOR VACCINE, Cancer gene therapy, 4(5), 1997, pp. 320-321
INTRATUMORAL INJECTION OF GM-CSF GENE ENCODED RECOMBINANT VACCINIA VIRUS ELICITS POTENT ANTITUMOR RESPONSE IN A MURINE MELANOMA MODEL
Authors: JU DW CAO XT ACRES B
Citation: Dw. Ju et al., INTRATUMORAL INJECTION OF GM-CSF GENE ENCODED RECOMBINANT VACCINIA VIRUS ELICITS POTENT ANTITUMOR RESPONSE IN A MURINE MELANOMA MODEL, Cancer gene therapy, 4(2), 1997, pp. 139-144
INVOLVEMENT OF MHC CLASS-I MOLECULE AND ICAM-1 IN THE ENHANCEMENT OF ADHESION AND CYTOTOXIC SUSCEPTIBILITY TO IMMUNE EFFECTOR-CELLS OF TUMOR-CELLS TRANSFECTED WITH THE INTERLEUKIN (IL)-2, IL-4 OR IL-6 GENE
Authors: CAO XT CHEN GY HE L ZHANG WP YU YZ WANG JL
Citation: Xt. Cao et al., INVOLVEMENT OF MHC CLASS-I MOLECULE AND ICAM-1 IN THE ENHANCEMENT OF ADHESION AND CYTOTOXIC SUSCEPTIBILITY TO IMMUNE EFFECTOR-CELLS OF TUMOR-CELLS TRANSFECTED WITH THE INTERLEUKIN (IL)-2, IL-4 OR IL-6 GENE, Journal of cancer research and clinical oncology, 123(11-12), 1997, pp. 602-608
Risultati: 1-25 | 26-30